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Utility of rpoB Gene Sequencing for Identification of Nontuberculous
Mycobacteria in the Netherlands
Rina de Zwaan,a Jakko van Ingen,b Dick van Soolingena,b
National Mycobacteria Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlandsa; Department of Medical Microbiology,
Radboud University Medical Center, Nijmegen, the Netherlandsb
In the Netherlands, clinical isolation of nontuberculous mycobacteria (NTM) has increased over the past decade. Proper identifi-
cation of isolates is important, as NTM species differ strongly in clinical relevance. Most of the currently applied identification
methods cannot distinguish between all differentMycobacterium species and complexes within species. rpoB gene sequencing
exhibits a promising level of discrimination among rapidly and slowly growing mycobacteria, including theMycobacterium
avium complex. In this study, we prospectively compared rpoB gene sequencing with our routine algorithm of reverse line blot
identification combined with partial 16S rRNA gene sequencing of 455 NTM isolates. rpoB gene sequencing identified 403 iso-
lates to species level as 45 different known species and identified 44 isolates to complex level, and eight isolates remained uniden-
tifiable to species level. In contrast, our reference reverse line blot assay with adjunctive 16S rRNA gene sequencing identified 390
isolates to species level (30 distinct species) and identified 56 isolates to complex level, and nine isolates remained unidentified.
The higher discriminatory power of rpoB gene sequencing results largely from the distinction of separate species within com-
plexes and subspecies. Also, Mycobacterium gordonae, Mycobacterium kansasii, and Mycobacterium interjectum were separated
into multiple groupings with relatively low sequence similarity (98 to 94%), suggesting that these are complexes of closely re-
lated species. We conclude that rpoB gene sequencing is a more discriminative identification technique than the combination of
reverse line blot and 16S rRNA gene sequencing and could introduce a major improvement in clinical care of NTM disease and
the research on the epidemiology and clinical relevance of NTM.
Nontuberculous mycobacteria (NTM) are environmental bac-teria that incidentally cause opportunistic infections in hu-
mans. In the Netherlands, an aging population and increasing
prevalence of chronic disorders like chronic obstructive pulmo-
nary disease (COPD) have led to an increase in clinical NTM iso-
lation, mainly from pulmonary specimens (1). To determine the
clinical relevance of NTM, the Statement by the American Tho-
racic Society and the Infectious Disease Society of America offers
an important support to guide clinicians (2). At present, more
than 160 distinct Mycobacterium species have been validly pub-
lished (http://www.bacterio.net/mycobacterium.html). The clin-
ical relevance of isolated NTM differs strongly by species, with a
spectrum ranging from species which should nearly always be
considered pathogenic (e.g., Mycobacterium kansasii and Myco-
bacterium malmoense) to typical saprophytes, like Mycobacterium
gordonae and Mycobacterium phlei (3). Optimal treatment regi-
mens also differ by species, with major differences between slowly
and rapidly growing NTM (4). Because of these differences in
clinical relevance and specific treatment regimens, accurate spe-
cies identification of isolated NTM is of the utmost importance.
Since the early 1990s, sequence analysis of the 16S rRNA gene
has served as the gold standard in identification of mycobacteria
(5). After the introduction of commercial line probe assays and
other molecular probe assays, most laboratories implemented
these assays as a rapid first identification to overcome the practical
or financial inaccessibility of DNA sequencers and to reduce turn-
around time. Although 16S rRNA gene sequencing offers much
more resolution in identification of NTM than line blot assays, it
still lacks discrimination for some groups of NTM, especially
among the rapid growers in theMycobacterium fortuitum andMy-
cobacterium chelonae-abscessus complexes (6, 7). Therefore, DNA
sequence analysis of the rpoB gene was suggested in previous stud-
ies as a more suitable tool for identification of NTM than 16S
rRNA genes (8), and promising results have been obtained both
among rapidly growing mycobacteria (RGM) (9) and within the
M. avium complex (8). It has also been observed that the rpoB
sequence-based phylogenetic tree was similar to a concatenated
tree on the basis of rpoB, hsp65, and 16S rRNA gene sequences (6).
In this study, we prospectively compared partial rpoB gene se-
quencing to our routine algorithm of reverse line blot identifica-
tion supplemented with partial 16S rRNA gene sequencing, test-
ing 455 clinical NTM isolates received at the Mycobacterium
reference laboratory at the National Institute for Public Health
and the Environment in the Netherlands (RIVM) during a 15-
month period.
MATERIALS AND METHODS
Clinical NTM isolates submitted to the RIVM from January 2010 to
March 2011 were subjected to reverse line blot identification (INNO-
LiPAMycobacteria v2 [Innogenetics, Ghent, Belgium]; referred to here as
LiPA). Isolates identified as Mycobacterium species by this assay but not
identifiable to species or complex level with the assay’s probes were then
identified by partial 16S rRNA gene sequence analysis starting from the
position corresponding to Escherichia coli position 28 (479 bp, including
the hypervariable regions A and B) (5, 10). Additionally, isolates were
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subjected to partial sequencing of the rpoB gene using previously pub-
lished primers (9).
Both the 16S rRNA gene and rpoB gene sequences were analyzed using
BioNumerics version 6.6 software (Applied Math, Belgium). The se-
quences were aligned with the GenBank database (NCBI), using the
Basic Local Alignment Search Tool (BLAST). For 16S rRNA gene se-
quencing, identification was based on 100% matches with type strains
or reference isolates of validly published species (http://www.bacterio.net
/mycobacterium.html) (11). Isolates without a propermatchwere labeled
“unidentified Mycobacterium species” (UMS) and numbered consecu-
tively. The rpoB gene sequences were interpreted as previously suggested
(8, 9); i.e., we tolerated 99.3% similarity to type strain sequences for slow
growers and 98.3% for rapid growers. Additionally, SGM and RGM iso-
lates with similarities between 94% and 99.3% or 98.3% to type strain
sequenceswere considered identified to complex level only. Isolates show-
ing less than 94% similarity to an accepted species were considered rpoB
unidentified Mycobacterium species (rUMS). Additionally, matches with
the Mycobacterium terrae complex strain sequences from the study of
Tortoli et al. (12) and “M. tilburgii” (13) were also accepted.
If rpoB sequencing results were not supported by GenBank results, the
16S rRNA gene was considered the gold standard. If rpoB sequencing
results were supported by LiPA, the LiPA result was considered correct
except when a match with another type strain in GenBank was found. In
cases of a match with more than one species within the cutoff value, we
selected the closest match.
Nucleotide sequence accession numbers. We have deposited the
Mycobacterium bohemicum (KJ729110), Mycobacterium heckeshornense
(KJ729109), and Mycobacterium conspicuum (HQ141573) sequences we
obtained in GenBank.
RESULTS
Screening of 455 NTM isolates using the reverse line blot assay.
Using the LiPA, 417 (92%) of the 455 isolates could be identified
to species or complex level based on hybridization with one of the
probes identifying a total of 17NTM species and threeNTMcom-
plexes (Table 1). Thirty-eight isolates (8%) could not be identified
beyond the genus Mycobacterium, as hybridization with the My-
cobacterium genus probe but not with a species- or complex-spe-
cific probe was observed in the reverse line assay.
16S rRNA gene versus rpoB gene sequencing. Thirty-eight
isolates were classified as Mycobacterium species with the LiPA
assay andunderwent additional 16S rRNAgene sequencing. These
38 isolates were assigned to 26 different species (27 sequence types
in 16S rRNA gene analysis versus 31 sequence types in rpoB gene
sequencing), of which five were possibly novel species, and three
different isolates could not be identified beyond the M. terrae
complex level.
Eleven isolates had matching results in both 16S rRNA gene
and rpoB gene sequencing and were identified asM. phlei (n 2),
M. lentiflavum (n 2), M. branderi (n 1), M. florentinum (n
1),M. shimoidei (n 1),M. triviale (n 1),M. goodii (n 1),M.
mucogenicum (n 1), or M. iranicum (n 1) (14). Two isolates
showed more than 98.3% similarity with established species by
rpoB gene sequencing but showed one base pair mismatch with
16S rRNA gene sequencing:M. phlei (n 1) andM. novocastrense
(n 1). Three isolates could only be identified by 16S rRNA gene
sequences, as no rpoB reference sequence was available for these
species: M. bohemicum (n  1), M. heckeshornense (n  1), M.
conspicuum (n 1) (Fig. 1, 2, and 3).
Six isolates belonged to the M. terrae complex on the basis of
both the 16S and rpoB analysis. Three isolates gave a sufficient
match with 16S rRNA gene and rpoB gene sequences and were
identified as Mycobacterium arupense, M. terrae, and Mycobacte-
rium kumamotonense (12). The other three isolates could not be
assigned to a species but did belong to the M. terrae complex
according to both methods, having an rpoB gene sequence simi-
larity of94% to validly publishedM. terrae complex species (10)
(Fig. 1 and 2).
Two isolates matched M. fortuitum CIP104534T 16S rRNA
gene sequencing but did not hybridize with the M. fortuitum-M.
peregrinum complex (MFO) probe of the LiPA assay. In rpoB gene
sequencing, the two exhibited 99.7% similarity with M. hous-
tonense ATCC 49403T (AY147173) and a similarity of 98.8% with
M. fortuitum CIP104534T (AY147165) (Fig. 1 and 3).
Seven isolates identified as Mycobacterium interjectum on the
basis of the 16S rRNA gene sequence were separated into three
sequence types on the basis of the rpoB. Three isolatesmatchedM.
interjectum DSM44064 (HM022207); the other two sequence
types, comprising of four isolates, revealed only 97.9% similarity
to the type strain sequence.
For the remaining seven isolates, no good match could be
found with either sequencing method. Three isolates were
grouped together (rUMS_06) in both methods, but no sufficient
match was found with any known Mycobacterium species with
eithermethod; the closestmatch (98.7%)on the basis of 16S rRNA
genes was with Mycobacterium agri DSM44515, and in rpoB gene
sequencing, the closest match, only 93%, was withMycobacterium
elephantis (Fig. 1 and 3).
For four unique isolates (rUMS_02, rUMS_03, rUMS_04,
and rUMS_05), no match could be found in both sequencing
methods. In 16S rRNA gene sequencing, rUMS_02 (isolate
NLA001002310) (Fig. 1) was a 100%match forMycobacterium sp.
strain FI-06081 (DQ986506); the closest species match wasMyco-
bacterium marinum. The other three had 99.0% similarity with
TABLE 1 Reverse line blot assay results
Line
INNO-LiPA
probe Species
No. of
samples
No. (%) with
matching result
by rpoB
sequencing
2 MYC Mycobacterium species 38a 36 (94.7)
3 MTBC M. tuberculosis complex 0
4 MKA-1 M. kansasii I 33 35 (81.4)
5 MKA-2 M. kansasii II 7
6 MKA-3 M. kansasii III (type III-V
M. gastri)
3
7 MXE M. xenopi 6 6 (100)
8 MGO M. gordonae 62 49 (79.0)
9 MGV M. genavense 0
10 MSI M. simiae 5 4 (80)
11 MMU M. marinum/M. ulcerans 16 16 (100)
12 MCE M. celatum 0
13 MAIS M. avium complex (MAC) 26 11 (42.3)
14 MAV M. avium 112 112 (100)
15 MIN-1 M. intracellulare (sequevar
Min-A, -B, -C, and -D)
18 15 (83.3)
16 MIN-2 M. chimaera (formerly M.
intracellulare sequevar
MAC-A)
24 22 (91.7)
17 MSC M. scrofulaceum 2 0 (0)
18 MML M. malmoense 15 15 (100)
19 MHP M. haemophilum 2 2 (100)
20 MCH-1 M. chelonae 21 20 (95.2)
21 MCH-2 M. abscessus 38 24 (63.2)
22 MCH-3 M. chelonae (group I) 0
23 MFO M. fortuitum-M. peregrinum
complex
27 19 (70.4)
24 MSM M. smegmatis 0
TOTAL 455 384 (84.4)
a Additional partial 16S rRNA gene sequencing was performed.
rpoB Gene Sequencing of NTM
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FIG 1 Similarity on the basis of 16S rRNA gene sequences (n 38).
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Mycobacterium brisbanense, 97.3% similarity with M. triviale, and
99.6% similarity with Mycobacterium frederiksbergense in 16S
rRNAgene sequencing (Fig. 1). In rpoB gene sequencing, the near-
est species matches for these three isolates had 90% to 97% simi-
larities according to BLAST (Fig. 2 and 3).
INNO-LiPA assay versus rpoB gene sequencing. With the
LiPA, 417 of the 455 isolates could be identified beyond the genus
level. The majority of these isolates, 348/417 (83.5%), showed a
similar result in rpoB sequencing (Table 1).
All isolates ofMycobacterium xenopi (n 6),M.marinum (n
16), and M. haemophilum (n 2) showed more than 99.3% rpoB
gene sequence similarity with one another; for M. haemophilum
isolates, only a 97.9% similarity with the type strain was observed
(Fig. 2).
Four (80%) of the five isolates identified as Mycobacterium
simiae in the LiPA assay exhibited a similarity of more than 99.3%
but only 98.3% similarity with the M. simiae type strain, ATCC
25275 (GQ153313). One isolate identified as M. simiae by the
LiPA assay was identified as M. tilburgii on the basis of its rpoB
gene sequence (Fig. 2).
The LiPA assay identified threeM. kansasii subtypes (MKA1 to
-3; Mycobacterium gastri is included in MKA-3). The 43 isolates
identified as M. kansasii by the LiPA assay were separated into
three discordant groupings by rpoB gene sequencing, with
99.7% sequence similarity within these three groups (Fig. 2 and
Table 2).
According to the LiPA assay, all M. avium (n  112) and M.
malmoense (n 15) isolates had an rpoB gene sequence similarity
of more than 99.3% with the reference strain Mycobacterium
avium subsp. hominissuis (IWGMT49; EF521911) or M. mal-
moense ATCC 29571T (GQ153314). The otherM. avium-intracel-
lulare-scrofulaceum group (MAIS; according to LiPA) isolates
showed more variation and could be assigned to seven published
species, as depicted in Table 3 and Fig. 2.
Sixty-two isolates reacted with the M. gordonae probe of the
LiPA, of which 49 (79%) showed 99.3% rpoB gene sequence
similarity with M. gordonae ATCC 14770T (JF346873). The re-
maining 13 M. gordonae isolates identified by the LiPA showed
only 95.8% rpoB gene sequence similarity and were classified as
M. gordonae complex (Fig. 2).
The LiPA separates the M. chelonae-abscesses complex into three
different groups (MCH1 to -3). Isolates reacting only with MCH-1
were referred to as M. chelonae, whereas isolates that reacted with
both MCH-1 and MCH-2 were referred to as M. abscessus. Reac-
tions with the MCH-3 probe were not seen (Table 1). Twenty out
of 21 (95.2%) isolates that were identified as M. chelonae by the
LiPAwere identified equally by rpoB gene sequencing (Fig. 3).One
isolated showed 95.9% similarity with the M. chelonae ATCC
19237T (EU109289) and was classified as M. chelonae complex.
Of the 38 isolates identified as M. abscessus by the LiPA, 24
(63.2%) were identified asMycobacterium abscessus subsp. absces-
sus and 14 (36.8%) as Mycobacterium abscessus subsp. bolletii by
rpoB gene sequencing. Within the M. abscessus subsp. bolletii
group, a separate branch was revealed for the former Mycobacte-
FIG 2 Comparison of identification on the basis of the LiPA assay and phy-
logeny on the basis of partial rpoB sequencing for slow-growing nontubercu-
lous mycobacteria (n 355).
rpoB Gene Sequencing of NTM
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FIG 3 Comparison of identification on the basis of the LiPA assay and phylogeny on the basis of partial rpoB sequencing for rapidly growing nontuberculous
mycobacteria (n  100). “M. abscessus subsp. bolletii” refers to organisms previously known as M. bolletii; “M. abscessus subsp. bolletii*” refers to organisms
previously known as M. massiliense.
2548 jcm.asm.org Journal of Clinical Microbiology
 o
n
 M
ay 1, 2017 by RADBO
UD UNIVERSITEIT NIJM
EG
EN
http://jcm.asm.org/
D
ow
nloaded from
 
rium massiliense, but it was within the cutoff value of 98.3%
(Fig. 3).
Twenty-seven isolates were identified as M. fortuitum-M. per-
egrinum complex (MFO) by the LiPA. Nineteen (70.4%) of these
isolates showed a high similarity with either theM. fortuitum (n
16) or M. peregrinum (n  3) type strain (Fig. 3); 16 isolates
showed 99.7% similarity with M. fortuitum CIP104534T
(AY147165). Two isolates had 99% sequence similarity to M.
houstonense ATCC 49403T (AY147173) but also 98.8% sequence
similarity with M. fortuitum CIP104534T (AY147165), although
these two isolates only reacted with the Mycobacterium genus
probe (MYC) of the LiPA assay and not with the M. fortuitum-M.
peregrinum complex (MFO) probe.
Three isolates matchedM. peregrinumATCC 14467T (JF712876)
and one isolate showed the highest similarities with M. alvei
CIP103464T (AY859697), but all four isolates showed98.3% simi-
larity with M. peregrinum, which is within the cutoff value of the
RGM. Four other species were identified within theM. fortuitum-M.
peregrinum complex as labeled by the LiPA assay; three isolates
showed rpoB gene sequence similarity of 99.2%withMycobacterium
conceptionense CIP108544T (AY859695), two showed similarity of
98.3% with Mycobacterium septicum ATCC 700731T (AY147167),
one matched Mycobacterium porcinum CIP105392T (AY262737),
and one showed a similarity of 99.1% with M. setense CIP109395T
(EU371506) (Fig. 3).
DISCUSSION
rpoB gene sequencing proved to be more discriminative than the
algorithm of LiPA with adjunctive 16S rRNA gene sequencing.
Combined, the LiPA assay and adjunctive 16S rRNA gene se-
quencing identified 390 of the 455 isolates (85.7%) as 30 validly
published species and 56 isolates (12.3%) up to complex level, and
nine isolates (2%) were assigned to five possibly novel species. By
rpoB sequencing, 403 isolates (88.5%) were identified up to spe-
cies level and assigned to 45 validly published species; 44 isolates
(9.7%) were identified up to complex or group level, and eight
isolates (1.8%) were assigned to six possibly novel species. In this
set of isolates, rpoB gene sequencing identified 15 more known
species than the LiPA with adjunctive 16S rRNA genes (Mycobac-
terium vulneris, M. colombiense, M. mantenii, M. timonense, M.
yongonense, M. heidelbergense, M. tilburgii, M. conceptionense, M.
porcinum, M. houstonense, M. septicum, M. peregrinum, M. alvei,
M. setense, andM.novocastrense). The discriminatory power of the
LiPA and 16S rRNA gene sequencing algorithm could have been
higher if strains identified as M. avium complex or M. fortui-
tum-M. peregrinum had also been subjected to 16S rRNA gene
sequencing. Nonetheless, the discriminatory power of partial 16S
rRNA gene sequencing is limited among NTM, particularly
among RGM (7, 11). This contributes to the value of the LiPA
assay, in addition to its being a more rapid approach than se-
quencing. Also, for 16S rRNA genes, it is difficult to differentiate
between species, because sequences can vary within species (7).
Two isolates (NLA001002096 and NLA001100042) were consid-
ered UMS on the basis of a 1-bp mismatch in 16S rRNA gene
sequences, whereas by rpoB sequencing, the isolates were identi-
fied to species level as M. phlei and M. novocastrense.
Additionally, rpoB gene sequencing showed diversity greater
than the cutoff for separate species designationwithin known spe-
cies, which could in time result in a more precise taxonomy of
NTM.
rpoB gene sequencing has been applied in several studies,
mostly concentrating on a certain group of NTM, like M. avium
complex (MAC) or RGM (8, 9). Two studies tested a larger vari-
ation of NTM species, from both human and veterinary samples
(15, 16). However, the general utility of rpoB sequencing for iden-
tification of NTM isolates received at a Mycobacterium reference
laboratory remained unclear. Two studies on the usefulness of
rpoB sequencing for identification reported a slightly lower per-
centage of isolates identified to species level: 84% in the study by
Simmon et al. of 139 human clinical isolates (16) and 80% in the
study by Higgins et al. of 386 animal isolates (15).
The largest difference between rpoB sequencing and the LiPA/
16S rRNA gene approach appears to be due to species being
grouped together by LiPA/16S rRNA gene but not by rpoB se-
quencing. Misidentification or oversimplified identification of
species by the LiPA has already been reported for M. heidelber-
gense, M. mantenii, and M. parascrofulaceum; also, the M. fortui-
tum-peregrinum complex consists of more valid species than M.
fortuitum andM. peregrinum (17, 18).We also noted that the LiPA
did not identify two M. houstonense isolates as M. fortuitum-per-
egrinum complex members, though by 16S rRNA gene and rpoB
gene sequencing, this species is part of the M. fortuitum-peregri-
num complex.
Both the M. haemophilum and M. simiae isolates in our study
group had a high degree of mutual similarity but did not show a
high similarity with the type strain rpoB gene sequence present in
TABLE 2 Correlation between rpoB sequencing and LiPA identification
of M. kansasii isolates
rpoB sequencing result
No. of samples with LiPA result
MKA1 MKA2 MKA3 Total
M. kansasii STa 30 3 33
M. kansasii ST2 3 3 1 7
M. kansasii ST3 1 2 3
Total 33 7 3 43
a More than 99.3% similarity with M. kansasii ATCC 12478T (HQ880687). ST,
sequence type.
TABLE 3 Correlation between rpoB sequencing and LiPA identification
of M. avium-intracellulare-scrofulaceum group isolates
rpoB identification
No. of samples with LiPA result
MAIS MIN-1 MIN-2 MSC
M. intracellulare 6 15 2 0
M. chimaeraa 0 0 22 0
MACb 11 2 0 0
M. yongonense 0 1 0 0
M. colombiense 2 0 0 0
M. mantenii 1 0 0 0
M. timonense 3 0 0 0
M. vulneris 1 0 0 0
M. heidelbergense 1 0 0 0
M. parascrofulaceum 0 0 0 2
rUMS01 1 0 0 0
Total 26 18 24 2
a 100% match with M. chimaera CIP107892T (GQ153309) and99.3% sequence
similarity with M. intracellulare.
b More than 94% but less than 99.3% similarity with MAC species.
rpoB Gene Sequencing of NTM
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GenBank. The taxonomy in theM. simiae group has been updated
frequently in the past few years and has been found to be more
diverse than previously thought (19, 20). The variation could also
be due to a poorly selected type strain, as was also noted for M.
terrae by Tortoli et al. (12).
Our findings indicate that there is more genetic variation
within a species than previously suspected, for example, in M.
interjectum. Other NTM species have already been grouped into
complexes which cluster closely together on the basis of at least
94% similarity, like the MAC, M. chelonae-abscessus complex, M.
fortuitum complex, and M. terrae complex (12). But a higher de-
gree of genetic divergence could be disclosed in groupings like M.
kansasii (21) and M. gordonae (22). Perhaps these two should be
regarded as complexes of closely related species, rather than single
species.
Four groups of species had debatable mutual similarities: M.
intracellulare and M. chimaera (formerly M. intracellulare seque-
varMac-A [23]),M. fortuitum andM. houstonense,M. peregrinum
and M. alvei, and the extensively discussed M. abscessus subsp.
bolletii, which was previously divided into M. bolletii and M.
massiliense (24). The latter three showedmore similarity with one
another than the cutoff value for separate species status allows (8,
9), but rpoB gene sequencing does separate them into different
branches, enabling discrimination of the different groupings.
Most strains identified as M. chimaera by the LiPA had identical
rpoB gene sequences but shared a very high degree of similarity
with themore variableM. intracellulare. On the basis of rpoB gene
sequencing, M. chimaera seems to be a subspecies of M. intracel-
lulare.
The separate species status of M. intracellulare, M. chimaera,
M. fortuitum,M. houstonense,M. peregrinum,M. alvei,M. bolletii,
andM. massiliense remains questionable if the cutoffs for separate
species status (8, 9) are strictly applied. It should be noted that
Adékambi et al. (9) found a 98.2% similarity betweenM. fortuitum
and M. houstonense, and Ben Salah et al. (8) found a 99.2% simi-
larity betweenM. intracellulare andM. chimaera, which is enough
variation to justify separation into different species according to
the cutoff value (8, 9). However, Simmon et al. also noted a lack
of interspecies variability for these four species (16). The gen-
eral problem is that in mycobacteriology, no cutoffs for sepa-
rate species based on any genetic targets have been set and
agreed upon (7).
The high degree of similarity between the subspecies and the
complicated interpretation of rpoB gene sequencing results have
led to a change in status for M. massiliense and M. bolletii from
separate species to subspecies, and they are now referred to as M.
abscessus subsp. bolletii (24). However, separation of M. massil-
iense fromM. bolletii andM. abscessus subsp. abscessus has clinical
relevance, as M. massiliense is susceptible to macrolides; e.g., cla-
rithromycin-based treatment regimens are more successful in
treatment of M. massiliense disease than disease caused by M.
bolletii and M. abscessus subsp. abscessus (25).
It has been noted that rpoB sequencing alone can, in rare in-
stances, misidentify the M. abscessus subspecies, possibly due to
horizontal gene transfer (26). However, horizontal gene transfer
would also affect performance of other targets, such as the hsp65
gene (11, 26). rpoB gene sequencing is still a reasonable first ap-
proach; forM. abscessus an interesting second step is erm(41) gene
sequencing, which identifies the different subspecies and predicts
macrolide susceptibility (25).
One limitation of rpoB sequencing is the absence of sequence
data for type or reference strains of the less commonly encoun-
tered NTMs in the GenBank database, as we recorded for M. bo-
hemicum, M. heckeshornense, and M. conspicuum. rpoB gene se-
quences identified beyond doubt using other targets should be
added to the GenBank database. The other limitation, relevant to
any genetic target, is the lack of quality assurance in public se-
quence databases, which may hamper comparisons and requires
strict monitoring of results (7, 11). Public databases inherently
suffer from data quality issues, whereas closed, quality-controlled
database inherently suffer from data quantity issues, i.e., they are
incomplete (7, 11).
Identifications of NTMbased on one genetic targetmay always
result in limited reliability, and sequencing of additional targets
will increase the quality of identifications. To resolve issues related
to taxonomic status, the definite separate species definition should
be provided by whole-genome sequencing of a large collection of
NTM isolates. Amore exact identification will be most helpful for
studying differences in clinical relevance, environmental sources,
and epidemiology of human NTM disease (3).
In conclusion, partial rpoB gene sequencing has a higher dis-
criminatory power than a LiPA with adjunctive partial 16S rRNA
gene sequencing.Most clinically important species have rpoB gene
sequences of type strains available through public databases. On
the basis of the data presented here, we consider rpoB sequencing
an appropriate first-line identification method for NTM isolated
from human samples.
REFERENCES
1. van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen
D. 2010. In vitro drug susceptibility of 2275 clinical non-tuberculous
Mycobacterium isolates of 49 species in The Netherlands. Int. J. Anti-
microb. Agents 35:169–173. http://dx.doi.org/10.1016/j.ijantimicag
.2009.09.023.
2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C,
Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman
M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K. 2007.
An official ATS/IDSA statement: diagnosis, treatment, and prevention of
nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med.
175:367–416. http://dx.doi.org/10.1164/rccm.200604-571ST.
3. van Ingen J, Bendien SA, de Lange WC, Hoefsloot W, Dekhuijzen PN,
BoereeMJ, van Soolingen D. 2009. Clinical relevance of non-tuberculous
mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands.
Thorax 64:502–506. http://dx.doi.org/10.1136/thx.2008.110957.
4. van Ingen J. 2013. Diagnosis of nontuberculous mycobacterial infections.
Sem. Respir. Crit. Care Med. 34:103–109. http://dx.doi.org/10.1055/s
-0033-1333569.
5. Springer B, Bottger EC, Kirschner P, Wallace RJ, Jr. 1995. Phylogeny of the
Mycobacterium chelonae-like organism based on partial sequencing of the
16S rRNAgene andproposal ofMycobacteriummucogenicumsp.nov. Int. J.
Syst. Bacteriol. 45:262–267. http://dx.doi.org/10.1099/00207713-45-2-262.
6. Tortoli E. 2012. Phylogeny of the genus Mycobacterium: many doubts,
few certainties. Infect. Genet. Evol. 12:827–831. http://dx.doi.org/10.1016
/j.meegid.2011.05.025.
7. Turenne CY, Tschetter L, Wolfe J, Kabani A. 2001. Necessity of quality-
controlled 16S rRNA gene sequence databases: identifying nontubercu-
lous Mycobacterium species. J. Clin. Microbiol. 39:3637–3648. http://dx
.doi.org/10.1128/JCM.39.10.3638-3648.2001.
8. Ben Salah I, Adekambi T, Raoult D, Drancourt M. 2008. rpoB sequence-
based identification of Mycobacterium avium complex species. Microbi-
ology 154:3715–3723. http://dx.doi.org/10.1099/mic.0.2008/020164-0.
9. Adékambi T, Colson P, Drancourt M. 2003. rpoB-based identification of
nonpigmented and late-pigmenting rapidly growing mycobacteria. J. Clin.
Microbiol. 41:5699–5708. http://dx.doi.org/10.1128/JCM.41.12.5699-5708
.2003.
10. Reischl U, Feldmann K, Naumann L, Gaugler BJ, Ninet B, Hirschel B,
Emler S. 1998. 16S rRNA sequence diversity in Mycobacterium celatum
de Zwaan et al.
2550 jcm.asm.org Journal of Clinical Microbiology
 o
n
 M
ay 1, 2017 by RADBO
UD UNIVERSITEIT NIJM
EG
EN
http://jcm.asm.org/
D
ow
nloaded from
 
strains caused by presence of two different copies of 16S rRNA gene. J.
Clin. Microbiol. 36:1761–1764.
11. Tortoli E. 2010. Standard operating procedure for optimal identification
of mycobacteria using 16S rRNA gene sequences. Stand. Genomic Sci.
3:145–152. http://dx.doi.org/10.4056/sigs.932152.
12. Tortoli E, Gitti Z, Klenk HP, Lauria S, Mannino R, Mantegani P,
Mariottini A, Neonakis I. 2013. Survey of 150 strains belonging to the
Mycobacterium terrae complex and description of Mycobacterium eng-
baekii sp. nov., Mycobacterium heraklionense sp. nov. and Mycobacte-
rium longobardum sp. nov. Int. J. Syst. Evol.Microbiol. 63:401–411. http:
//dx.doi.org/10.1099/ijs.0.038737-0.
13. Hartwig NG, Warris A, van de Vosse E, van der Zanden AG, Schulin-
Casonato T, van Ingen J, van Hest R. 2011. “Mycobacterium tilburgii”
infection in two immunocompromised children: importance of molecu-
lar tools in culture-negative mycobacterial disease diagnosis. J. Clin. Mi-
crobiol. 49:4409–4411. http://dx.doi.org/10.1128/JCM.05460-11.
14. Shojaei H, Daley C, Gitti Z, Hashemi A, Heidarieh P, Moore ER, Naser
AD, Russo C, van Ingen J, Tortoli E. 2013. Mycobacterium iranicum sp.
nov., a rapidly growing scotochromogenic species isolated from clinical
specimens on three different continents. Int. J. Syst. Evol. Microbiol. 63:
1383–1389. http://dx.doi.org/10.1099/ijs.0.043562-0.
15. Higgins J, Camp P, Farrell D, Bravo D, Pate M, Robbe-Austerman S.
2011. Identification of Mycobacterium spp. of veterinary importance us-
ing rpoB gene sequencing. BMC Vet. Res. 7:77. http://dx.doi.org/10.1186
/1746-6148-7-77.
16. Simmon KE, Kommedal O, Saebo O, Karlsen B, Petti CA. 2010.
Simultaneous sequence analysis of the 16S rRNA and rpoB genes by use of
RipSeq software to identify Mycobacterium species. J. Clin. Microbiol.
48:3231–3235. http://dx.doi.org/10.1128/JCM.00362-10.
17. Tortoli E, Pecorari M, Fabio G, Messino M, Fabio A. 2010. Commercial
DNA probes for mycobacteria incorrectly identify a number of less fre-
quently encountered species. J. Clin.Microbiol. 48:307–310. http://dx.doi
.org/10.1128/JCM.01536-09.
18. van Ingen J, de Zwaan R, Enaimi M, Dekhuijzen PN, Boeree MJ, van
SoolingenD. 2010. Re-analysis of 178 previously unidentifiableMycobac-
terium isolates in the Netherlands in 1999–2007. Clin. Microbiol. Infect.
16:1470–1474. http://dx.doi.org/10.1111/j.1469-0691.2010.03123.x.
19. van Ingen J, Tortoli E, Selvarangan R, Coyle MB, Crump JA, Morrissey
AB, Dekhuijzen PN, Boeree MJ, van Soolingen D. 2011. Mycobacterium
sherrisii sp. nov., a slow-growing non-chromogenic species. Int. J. Syst.
Evol. Microbiol. 61:1293–1298. http://dx.doi.org/10.1099/ijs.0.024752-0.
20. Tortoli E, Bottger EC, Fabio A, Falsen E, Gitti Z, Grottola A, Klenk HP,
Mannino R, Mariottini A, Messino M, Pecorari M, Rumpianesi F. 2011.
Mycobacterium europaeum sp. nov., a scotochromogenic species related
to the Mycobacterium simiae complex. Int. J. Syst. Evol. Microbiol. 61:
1606–1611. http://dx.doi.org/10.1099/ijs.0.025601-0.
21. Picardeau M, Prod’Hom G, Raskine L, LePennec MP, Vincent V. 1997.
Genotypic characterization of five subspecies of Mycobacterium kansasii.
J. Clin. Microbiol. 35:25–32.
22. Itoh S, Kazumi Y, Abe C, Takahashi M. 2003. Heterogeneity of RNA
polymerase gene (rpoB) sequences of Mycobacterium gordonae clinical
isolates identified with a DNA probe kit and by conventional methods. J.
Clin.Microbiol. 41:1656–1663. http://dx.doi.org/10.1128/JCM.41.4.1656
-1663.2003.
23. Tortoli E, Rindi L, Garcia MJ, Chiaradonna P, Dei R, Garzelli C,
Kroppenstedt RM, Lari N, Mattei R, Mariottini A, Mazzarelli G, Murcia
MI, Nanetti A, Piccoli P, Scarparo C. 2004. Proposal to elevate the
genetic variant MAC-A, included in the Mycobacterium avium complex,
to species rank as Mycobacterium chimaera sp. nov. Int. J. Syst. Evol.
Microbiol. 54:1277–1285. http://dx.doi.org/10.1099/ijs.0.02777-0.
24. Leao SC, Tortoli E, Euzeby JP, Garcia MJ. 2011. Proposal that Myco-
bacterium massiliense and Mycobacterium bolletii be united and reclas-
sified asMycobacterium abscessus subsp. bolletii comb. nov., designation
of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended
description of Mycobacterium abscessus. Int. J. Syst. Evol. Microbiol. 61:
2311–2313. http://dx.doi.org/10.1099/ijs.0.023770-0.
25. Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kook YH. 2010. Myco-
bacterium massiliense is differentiated from Mycobacterium abscessus
andMycobacterium bolletii by erythromycin ribosomemethyltransferase
gene (erm) and clarithromycin susceptibility patterns. Microbiol. Immu-
nol. 54:347–353. http://dx.doi.org/10.1111/j.1348-0421.2010.00221.x.
26. Macheras E, Roux AL, Bastian S, Leao SC, Palaci M, Sivadon-Tardy V,
Gutierrez C, Richter E, Rusch-Gerdes S, Pfyffer G, Bodmer T, Cambau
E, Gaillard JL, Heym B. 2011. Multilocus sequence analysis and rpoB
sequencing of Mycobacterium abscessus (sensu lato) strains. J. Clin. Mi-
crobiol. 49:491–499. http://dx.doi.org/10.1128/JCM.01274-10.
rpoB Gene Sequencing of NTM
July 2014 Volume 52 Number 7 jcm.asm.org 2551
 o
n
 M
ay 1, 2017 by RADBO
UD UNIVERSITEIT NIJM
EG
EN
http://jcm.asm.org/
D
ow
nloaded from
 
